Drug Profile
Research programme: 9-Aza-anthrapyrazoles
Alternative Names: 9-Aza-APs-BoehringerLatest Information Update: 03 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source; Roche
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 05 May 1999 New profile
- 05 May 1999 Preclinical development for Cancer in Italy (Unknown route)
- 05 May 1999 Preclinical development for Cancer in USA (Unknown route)